Mirum Pharmaceuticals, Inc.
MIRM
$96.55
$3.914.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.73M | 2.91M | -5.86M | -14.68M | -23.79M |
| Total Depreciation and Amortization | 6.07M | 6.06M | 6.06M | 6.05M | 6.06M |
| Total Amortization of Deferred Charges | 436.00K | 443.00K | 427.00K | 433.00K | 416.00K |
| Total Other Non-Cash Items | 19.29M | 18.13M | 17.97M | 17.53M | 13.93M |
| Change in Net Operating Assets | -14.01M | 12.15M | -6.56M | -11.30M | -1.68M |
| Cash from Operations | 6.07M | 39.68M | 12.04M | -1.96M | -5.07M |
| Capital Expenditure | -600.00K | -187.00K | -126.00K | -41.00K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.61M | -2.04M | -6.47M | -16.09M | 661.00K |
| Cash from Investing | 1.01M | -2.23M | -6.60M | -16.13M | 641.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.00M | 16.10M | 8.69M | 6.36M | 5.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.00M | 16.10M | 8.69M | 6.36M | 5.34M |
| Foreign Exchange rate Adjustments | -408.00K | 349.00K | 2.23M | 1.06M | -1.38M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.66M | 53.90M | 16.36M | -10.68M | -466.00K |